NovaVive Overview

  • Founded
  • 2014

  • Status
  • Private

  • Employees
  • 10

  • Latest Deal Type
  • Angel

  • (Cancelled)
  • Investors
  • 1

NovaVive General Information


Owner and operator of a Canadian-based immunobiology company that manufactures and sells immunotherapeutic products based on mycobacterium cell wall fraction (MCWF) technology. The company's products are regulator-approved for the treatment of various diseases in cattle, horses, and dogs in the U.S., Canada, Australia and New Zealand. It also has an active development program to assess additional diseases that could be treated with its core technology.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Other Healthcare Technology Systems
Other Industries
Other Pharmaceuticals and Biotechnology
Social/Platform Software
Primary Office
  • 15 Dairy Avenue
  • Napanee, Ontario K7R 1M4
  • Canada
+1 (613) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NovaVive Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Angel (individual) 19-Dec-2018 Cancelled Generating Revenue
2. Angel (individual) 20-Jun-2016 Cancelled Generating Revenue
1. Angel (individual) Completed Generating Revenue
To view NovaVive’s complete valuation and funding history, request access »

NovaVive Executive Team (2)

Name Title Board Seat Contact Info
Jennifer Shea Co-Founder, Vice-President of Investor Relations and Business Development & Board Member
Graeme McRae Co-Founder, President & Chairman
To view NovaVive’s complete executive team members history, request access »

NovaVive Board Members (3)

Name Representing Role Since
Graeme McRae Self Co-Founder, President & Chairman 000 0000
Jennifer Shea NovaVive Co-Founder, Vice-President of Investor Relations and Business Development & Board Member 000 0000
Stan Alkemade NovaVive Board Member 000 0000
To view NovaVive’s complete board members history, request access »

NovaVive Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NovaVive Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
NovaVive LP Limited Partner Minority 000 0000 000000 0
To view NovaVive’s complete investors history, request access »